Literature DB >> 31161551

miR-22-5p and miR-29a-5p Are Reliable Reference Genes for Analyzing Extracellular Vesicle-Associated miRNAs in Adipose-Derived Mesenchymal Stem Cells and Are Stable under Inflammatory Priming Mimicking Osteoarthritis Condition.

Enrico Ragni1, Carlotta Perucca Orfei2, Paola De Luca2, Marco Viganò2, Alessandra Colombini2, Gaia Lugano2, Valentina Bollati3, Laura de Girolamo2.   

Abstract

During the last two decades, mesenchymal stem cells (MSCs) gained a place of privilege in the field of regenerative medicine. Recently, extracellular vesicles (EVs) have been identified as major mediators of MSCs immunosuppressive as well as pro-regenerative activities in many disease models, including inflammatory/degenerative conditions as joint diseases and osteoarthritis. In order to shed light on EVs potential, a rigorous profiling of embedded proteins, lipids and nucleic acids (mRNA/miRNA) is mandatory. Nevertheless, reliable strategies to efficiently score miRNA cargo and modulation under diverse experimental conditions or treatments are missing. The aim of this work was to identify reliable reference genes (RGs) to analyze miRNA content in EVs secreted by adipose-derived MSCs (ASCs) and verify their consistency under inflammatory conditions that were proposed to enhance ASC-EVs immunomodulatory and regenerative potential. RefFinder algorithm, that integrates the currently available major computational programs (geNorm, NormFinder, BestKeeper, and Delta Ct method), allowed to identify miR-22-5p and miR-29a-5p as the most stable RGs. Notably, both miRNAs maintained the highest stability when EVs isolated from IFNg-treated ASCs were included in the analysis. In addition, considerable effects of suboptimal RGs choice on the reliable quantification of miRNAs involved at different levels (tissue homeostasis or macrophage polarization) in the osteoarthritis phenotype, and thus considered as promising therapeutic molecule, have clearly been demonstrated. In conclusion, a proper normalization method is not only needed for research purposes but also mandatory to characterize clinical products and predict their therapeutic potential, especially in the emerging field of MSCs derived-EVs as new tools for regenerative medicine.

Entities:  

Keywords:  Adipose-derived mesenchymal stem cells; Extracellular vesicles; Osteoarthritis; Reference gene; miRNA

Mesh:

Substances:

Year:  2019        PMID: 31161551     DOI: 10.1007/s12015-019-09899-y

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  48 in total

1.  Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells.

Authors:  M J Crop; C C Baan; S S Korevaar; J N M Ijzermans; M Pescatori; A P Stubbs; W F J van Ijcken; M H Dahlke; E Eggenhofer; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

2.  Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.

Authors:  G M van Buul; E Villafuertes; P K Bos; J H Waarsing; N Kops; R Narcisi; H Weinans; J A N Verhaar; M R Bernsen; G J V M van Osch
Journal:  Osteoarthritis Cartilage       Date:  2012-07-05       Impact factor: 6.576

3.  Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.

Authors:  Bénédicte Puissant; Corinne Barreau; Philippe Bourin; Cyril Clavel; Jill Corre; Christine Bousquet; Christine Taureau; Béatrice Cousin; Michel Abbal; Patrick Laharrague; Luc Penicaud; Louis Casteilla; Antoine Blancher
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

4.  Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Authors:  Rosa Yañez; María Luisa Lamana; Javier García-Castro; Isabel Colmenero; Manuel Ramírez; Juan A Bueren
Journal:  Stem Cells       Date:  2006-07-27       Impact factor: 6.277

5.  Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges.

Authors:  Sujata Law; Samaresh Chaudhuri
Journal:  Am J Stem Cells       Date:  2013-03-08

Review 6.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

7.  Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration.

Authors:  Tiziana Montemurro; Mariele Viganò; Enrico Ragni; Mario Barilani; Valentina Parazzi; Valentina Boldrin; Cristiana Lavazza; Elisa Montelatici; Federica Banfi; Eleonora Lauri; Silvia Giovanelli; Marco Baccarin; Silvana Guerneri; Rosaria Giordano; Lorenza Lazzari
Journal:  Eur J Cell Biol       Date:  2016-04-16       Impact factor: 4.492

8.  Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.

Authors:  Manuel A González; Elena Gonzalez-Rey; Laura Rico; Dirk Büscher; Mario Delgado
Journal:  Gastroenterology       Date:  2008-11-27       Impact factor: 22.682

9.  Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities.

Authors:  M J Hoogduijn; M J Crop; A M A Peeters; G J V M Van Osch; A H M M Balk; J N M Ijzermans; W Weimar; C C Baan
Journal:  Stem Cells Dev       Date:  2007-08       Impact factor: 3.272

Review 10.  Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies.

Authors:  Francesca Veronesi; Melania Maglio; Matilde Tschon; Nicolò Nicoli Aldini; Milena Fini
Journal:  J Biomed Mater Res A       Date:  2013-08-07       Impact factor: 4.396

View more
  13 in total

Review 1.  Extracellular vesicles as novel approaches for the treatment of osteoarthritis: a narrative review on potential mechanisms.

Authors:  Saman Shakeri Jousheghan; Mohammadreza Minator Sajjadi; Saber Shakeri Jousheghan; Seyyed-Mohsen Hosseininejad; Arash Maleki
Journal:  J Mol Histol       Date:  2021-09-12       Impact factor: 2.611

Review 2.  The non-coding RNA interactome in joint health and disease.

Authors:  Shabana A Ali; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2021-09-29       Impact factor: 20.543

Review 3.  Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations.

Authors:  Dragan Primorac; Vilim Molnar; Eduard Rod; Željko Jeleč; Fabijan Čukelj; Vid Matišić; Trpimir Vrdoljak; Damir Hudetz; Hana Hajsok; Igor Borić
Journal:  Genes (Basel)       Date:  2020-07-26       Impact factor: 4.096

Review 4.  Experimental Therapeutics for the Treatment of Osteoarthritis.

Authors:  Gundula Schulze-Tanzil
Journal:  J Exp Pharmacol       Date:  2021-02-11

5.  Cartilage Protective and Immunomodulatory Features of Osteoarthritis Synovial Fluid-Treated Adipose-Derived Mesenchymal Stem Cells Secreted Factors and Extracellular Vesicles-Embedded miRNAs.

Authors:  Enrico Ragni; Alessandra Colombini; Marco Viganò; Francesca Libonati; Carlotta Perucca Orfei; Luigi Zagra; Laura de Girolamo
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

6.  miRNA Reference Genes in Extracellular Vesicles Released from Amniotic Membrane-Derived Mesenchymal Stromal Cells.

Authors:  Enrico Ragni; Carlotta Perucca Orfei; Antonietta Rosa Silini; Alessandra Colombini; Marco Viganò; Ornella Parolini; Laura de Girolamo
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

7.  Expression of miR-204 in patients with osteoarthritis and its damage to chondrocytes.

Authors:  Xiaodong Liu; Feng Gao; Weikang Wang; Jinglong Yan
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-06-01       Impact factor: 2.041

8.  Innovative Visualization and Quantification of Extracellular Vesicles Interaction with and Incorporation in Target Cells in 3D Microenvironments.

Authors:  Enrico Ragni; Silvia Palombella; Silvia Lopa; Giuseppe Talò; Carlotta Perucca Orfei; Paola De Luca; Matteo Moretti; Laura de Girolamo
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

Review 9.  Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application.

Authors:  Byung-Chul Lee; Kyung-Sun Kang
Journal:  Stem Cell Res Ther       Date:  2020-09-14       Impact factor: 6.832

10.  Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.

Authors:  Ruihong Yuan; Xiaoming Dai; Yisong Li; Chunshan Li; Liu Liu
Journal:  Mol Med Rep       Date:  2021-09-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.